Intellia Therapeutics, Inc. (NTLA)
NGM – Real Time Price. Currency in USD
12.06
+0.04 (0.33%)
Market open: Aug 12, 2026, 1:43 PM EDT
12.04
+0.02 (0.18%)
Previous after-hours: Aug 11, 2026, 7:57 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
12.06
+0.04 (0.33%)
Market open: Aug 12, 2026, 1:43 PM EDT
12.04
+0.02 (0.18%)
Previous after-hours: Aug 11, 2026, 7:57 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $106.1M significantly exceed its total debt $73.4M, ensuring strong financial flexibility
Total current assets $527.8M exceed Total current liabilities $79.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$84.9M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.65 | 6.05 | 10 | |
| Quick ratio | 6.65 | 5.63 | 10 | |
| Debt to Equity | 0.10 | 0.30 | 9.0 | |
| Debt to Assets | 0.09 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 52M | 36M | 58M | 68M | 60M |
| Gross Profit | 45M | 27M | 48M | 52M | 44M |
| Operating Income | -458M | -515M | -534M | -441M | -423M |
| Net Income | -474M | -481M | -519M | -413M | -400M |
| EBITDA | -451M | -506M | -524M | -425M | -410M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -21.62 | 14.24 | 4.5 |
| Next quarter | -34.97 | 5.34 | 3.0 |
| Current year | -24.38 | 15.9 | 5.0 |
| Next year | 418.84 | 41.02 | 10 |
| Weighted average score | 5.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -49.09 | -10.8 | 1.23 | 27.68 | 3.8 |
| Y/Y | -46.22 | -5.3 | 18.37 | 14.96 | 4.8 |
| 3y average | 15.36 | 3.72 | 14.19 | -5.38 | 5.5 |
| 5y average | 12.15 | -33.07 | -15.56 | -81.29 | 2.5 |
| Weighted average score | 4.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |